
Sign up to save your podcasts
Or
Ketamine has gone from a recreational psychedelic to an approved treatment, and it has caught on in Silicon Valley in a big way. Are the long-term effects of using ketamine—recreationally or therapeutically—sufficiently known? Are we witnessing them right now?
Guest: Shayla Love, staff writer for the Atlantic.
Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.
Learn more about your ad choices. Visit megaphone.fm/adchoices
4.5
155155 ratings
Ketamine has gone from a recreational psychedelic to an approved treatment, and it has caught on in Silicon Valley in a big way. Are the long-term effects of using ketamine—recreationally or therapeutically—sufficiently known? Are we witnessing them right now?
Guest: Shayla Love, staff writer for the Atlantic.
Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.
Learn more about your ad choices. Visit megaphone.fm/adchoices
865 Listeners
8,555 Listeners
1,869 Listeners
30,862 Listeners
988 Listeners
32,197 Listeners
26,182 Listeners
2,854 Listeners
1,020 Listeners
7,739 Listeners
1,007 Listeners
3,461 Listeners
5,653 Listeners
59,056 Listeners
5,489 Listeners
2,019 Listeners
241 Listeners
23,951 Listeners
9,535 Listeners
553 Listeners
1,285 Listeners
15,848 Listeners
9,600 Listeners
1,193 Listeners
410 Listeners
610 Listeners
254 Listeners
59 Listeners
46 Listeners
94 Listeners
10 Listeners
5 Listeners